A detailed history of Clari Vest Asset Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 42,522 shares of ARWR stock, worth $895,088. This represents 0.08% of its overall portfolio holdings.

Number of Shares
42,522
Previous 42,522 -0.0%
Holding current value
$895,088
Previous $1.11 Million 25.52%
% of portfolio
0.08%
Previous 0.12%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$21.87 - $28.24 $218 - $282
10 Added 0.02%
42,522 $1.11 Million
Q1 2024

May 06, 2024

SELL
$27.21 - $39.48 $5,496 - $7,974
-202 Reduced 0.47%
42,512 $1.22 Million
Q4 2023

Feb 13, 2024

SELL
$21.2 - $31.03 $64,066 - $93,772
-3,022 Reduced 6.61%
42,714 $1.31 Million
Q3 2023

Nov 13, 2023

BUY
$26.2 - $36.08 $1,074 - $1,479
41 Added 0.09%
45,736 $1.23 Million
Q2 2023

Aug 14, 2023

SELL
$25.16 - $41.38 $171,163 - $281,508
-6,803 Reduced 12.96%
45,695 $1.63 Million
Q1 2023

May 08, 2023

BUY
$23.68 - $38.51 $757 - $1,232
32 Added 0.06%
52,498 $1.33 Million
Q4 2022

Feb 14, 2023

SELL
$28.0 - $40.56 $4,536 - $6,570
-162 Reduced 0.31%
52,466 $2.13 Million
Q3 2022

Nov 10, 2022

SELL
$29.63 - $48.31 $281,159 - $458,413
-9,489 Reduced 15.28%
52,628 $1.74 Million
Q2 2022

Aug 12, 2022

SELL
$27.79 - $50.61 $203,144 - $369,959
-7,310 Reduced 10.53%
62,117 $2.19 Million
Q1 2022

May 04, 2022

SELL
$39.62 - $69.97 $15,847 - $27,988
-400 Reduced 0.57%
69,427 $3.19 Million
Q4 2021

Feb 14, 2022

SELL
$58.09 - $82.51 $356,207 - $505,951
-6,132 Reduced 8.07%
69,827 $4.63 Million
Q3 2021

Nov 08, 2021

SELL
$58.38 - $84.96 $215,422 - $313,502
-3,690 Reduced 4.63%
75,959 $4.74 Million
Q2 2021

Aug 09, 2021

BUY
$62.15 - $90.32 $1.86 Million - $2.71 Million
29,959 Added 60.29%
79,649 $6.6 Million
Q1 2021

May 13, 2021

SELL
$61.35 - $90.47 $85,890 - $126,658
-1,400 Reduced 2.74%
49,690 $3.3 Million
Q4 2020

Feb 09, 2021

SELL
$43.82 - $85.37 $1.26 Million - $2.45 Million
-28,662 Reduced 35.94%
51,090 $3.92 Million
Q3 2020

Nov 09, 2020

SELL
$33.21 - $51.27 $97,139 - $149,964
-2,925 Reduced 3.54%
79,752 $3.44 Million
Q2 2020

Aug 12, 2020

BUY
$26.12 - $43.27 $27,817 - $46,082
1,065 Added 1.3%
82,677 $3.57 Million
Q1 2020

May 04, 2020

BUY
$20.56 - $63.12 $36,494 - $112,038
1,775 Added 2.22%
81,612 $2.35 Million
Q4 2019

Feb 12, 2020

SELL
$28.14 - $73.01 $1.16 Million - $3.01 Million
-41,186 Reduced 34.03%
79,837 $5.06 Million
Q3 2019

Nov 12, 2019

SELL
$26.26 - $34.86 $42,016 - $55,776
-1,600 Reduced 1.3%
121,023 $3.41 Million
Q2 2019

Aug 16, 2019

SELL
$17.43 - $28.82 $873,243 - $1.44 Million
-50,100 Reduced 29.01%
122,623 $3.25 Million
Q1 2019

May 13, 2019

BUY
$12.05 - $20.18 $231,456 - $387,617
19,208 Added 12.51%
172,723 $3.17 Million
Q4 2018

Feb 05, 2019

BUY
$10.74 - $19.7 $396,456 - $727,205
36,914 Added 31.66%
153,515 $1.91 Million
Q3 2018

Nov 07, 2018

SELL
$14.0 - $20.3 $135,954 - $197,133
-9,711 Reduced 7.69%
116,601 $2.24 Million
Q2 2018

Aug 10, 2018

BUY
$6.37 - $14.02 $356,159 - $783,886
55,912 Added 79.42%
126,312 $1.72 Million
Q1 2018

May 08, 2018

BUY
$3.72 - $7.64 $261,888 - $537,856
70,400 New
70,400 $507,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.